Advanced in Age-Related Macular Degeneration (ARMD)

Christina A. Korb

Gutenberg, RP, DE 
Advanced in Age-Related Macular Degeneration (ARMD)
Gutenberg, RP, DE 
OverviewLocationsClinical Research

Overview

Christina Korb practices in Gutenberg, Germany. Ms. Korb is rated as an Advanced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Vitrectomy, and Trabeculectomy.

Her clinical research consists of co-authoring 32 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 20 articles and participated in 1 clinical trial in the study of Age-Related Macular Degeneration (ARMD).

Gender
Female

Locations

Gutenberg, RP, Germany
Other Locations
Mainz, RP 55131, Germany
Bochum, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Correlation of Functional and Structural Outcomes With Serum Antibody Profiles in Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial
Correlation of Functional and Structural Outcomes With Serum Antibody Profiles in Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial
Enrollment Status: Completed
Publish Date: December 02, 2017
Intervention Type: Drug
Study Phase: Phase 4

32 Total Publications

Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation.
Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: June 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Korb's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile